Alanosine in Treating Patients With Cancer

Get Help Today

Looking for help or additional information? Contact us today.
First Name:
Last Name:
Email:
Phone:
Zip Code:
Comments:
Please enter the number below:
4530
Conditions: Lung Cancer/Malignant Mesothelioma/Pancreatic Cancer/Sarcoma
Start Date: March 1, 2003
Phase: Phase II
Status: Active, not recruiting
NCT ID: NCT00062283
Study Type: Interventional
Intervention: Drug: L-alanosine
Study Design: Treatment/Open Label
Results: No Results Available
Sponsors: Memorial Sloan-Kettering Cancer Center/National Cancer Institute (NCI)
Ages: Child/Adult/Senior
Enrollment: 0
Funded By: OTHER/NIH
First Received: June 5, 2003
End Date: January 1, 1900
Last Updated: July 23, 2008
Last Verified: April 1, 2005